A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...